Immune Determinants of T Cell Responses to Recall or De Novo Antigens

3,513
Total downloads
20k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 25 Nov 2025

A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project

Stefano Ugel
Akshita Gupta
Gianluca Spiteri
Pierpaolo Marchetti
Francesco De Sanctis
Shari Wouters
Angelina Konnova
Maria Grazia Lourdes Monaco
Angela Carta
23 more
Matilda Berkel

doi 10.3389/fimmu.2025.1707449

1,127 views

ORIGINAL RESEARCH

Published on 02 Oct 2025

Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease

Emily Parsons
Zhongyan Lu
Stephanie A. Richard
Amanda Zelkoski
Janifer Le
Naraen Palanikumar
Phuong Nguyen
Camille Alba
Gauthaman Sukumar
13 more
EPICC COVID-19 Cohort Study Group

doi 10.3389/fimmu.2025.1576903

1,860 views

ORIGINAL RESEARCH

Published on 14 May 2025

Compensatory mechanisms in γδ T cell-deficient chickens following Salmonella infection

Felix Tetzlaff
Ulrich Methner
Theresa von Heyl
Christian Menge
Benjamin Schusser
Angela Berndt

doi 10.3389/fimmu.2025.1576766

2,913 views

ORIGINAL RESEARCH

Published on 21 Mar 2025

Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity

David M. Florian
Michael Bauer
Amelie Popovitsch
Ingrid Fae
David N. Springer
Marianne Graninger
Marianna Traugott
Lukas Weseslindtner
Stephan W. Aberle
5 more
Judith H. Aberle

doi 10.3389/fimmu.2025.1501704

2,348 views
1 citation

ORIGINAL RESEARCH

Published on 25 Feb 2025

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine

Xiuwen Wang
Xiaodong Yang
Xin Zhang
Hongxia Yan
Junyan Jin
Zhenglai Ma
Junyi Duan
Guanghui Zhang
Tao Huang
6 more
Bin Su

doi 10.3389/fimmu.2025.1554409

2,393 views

ORIGINAL RESEARCH

Published on 07 Jan 2025

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens

Ibel Carri
Erika Schwab
Juan Carlos Trivino
Erika M. von Euw
Morten Nielsen
José Mordoh
María Marcela Barrio

doi 10.3389/fimmu.2024.1496204

5,967 views
9 citations

Share on

Frontiers in Immunology

T Cell Biology
Viral Immunology

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

20kTopic views
16kArticle views
3,513Article downloads

View impact

Articles

A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project

Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease

Compensatory mechanisms in γδ T cell-deficient chickens following Salmonella infection

Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine

VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens

Frontiers in Immunology

T Cell Biology

Viral Immunology